Elizabeth Masson-Hurlburt
2019
In 2019, Elizabeth Masson-Hurlburt earned a total compensation of $671.4K as Executive Vice President and Head of Clinical Operations at CorMedix, a 60% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $67,200 |
|---|---|
| Option Awards | $298,504 |
| Salary | $280,000 |
| Other | $25,734 |
| Total | $671,438 |
Masson-Hurlburt received $298.5K in option awards, accounting for 44% of the total pay in 2019.
Masson-Hurlburt also received $67.2K in non-equity incentive plan, $280K in salary and $25.7K in other compensation.
Rankings
In 2019, Elizabeth Masson-Hurlburt's compensation ranked 10,847th out of 13,971 executives tracked by ExecPay. In other words, Masson-Hurlburt earned more than 22.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,847 out of 13,971 | 22nd |
Division Manufacturing | 4,391 out of 5,701 | 23rd |
Major group Chemicals And Allied Products | 1,714 out of 2,200 | 22nd |
Industry group Drugs | 1,469 out of 1,886 | 22nd |
Industry Pharmaceutical Preparations | 1,085 out of 1,398 | 22nd |
Source: SEC filing on November 4, 2020.
Masson-Hurlburt's colleagues
We found four more compensation records of executives who worked with Elizabeth Masson-Hurlburt at CorMedix in 2019.